SCHEMBL6958354

SCHEMBL6958354

O=c1cc(O)cc(-c2cccc(Cl)c2)o1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.55
CA9 Q16790 2/20 0.55
GABRP O00591 5/20 0.53
GABRD O14764 5/20 0.53
GABRA1 P14867 5/20 0.53
GABRB1 P18505 5/20 0.53
GABRG2 P18507 5/20 0.53
GABRB3 P28472 5/20 0.53
GABRA5 P31644 5/20 0.53
GABRA3 P34903 5/20 0.53
GABRA2 P47869 5/20 0.53
GABRB2 P47870 5/20 0.53
GABRA4 P48169 5/20 0.53
GABRE P78334 5/20 0.53
GABRA6 Q16445 5/20 0.53
GABRG1 Q8N1C3 5/20 0.53
GABRG3 Q99928 5/20 0.53
GABRQ Q9UN88 5/20 0.53
PTPN1 P18031 1/20 0.48
PTGS2 P35354 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172775 0.82 SMN1; SMN2 (0.54) CA12CA9GABRPGABRDGABRA1
SCHEMBL28388874 0.81 GABRP (0.55) CA12CA9GABRPGABRDGABRA1
SCHEMBL8115383 0.81 CSNK2A2 (0.57) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8116989 0.81 QPCT (0.59) CA12CA9SLC9A1NOTUM
SCHEMBL6961356 0.80 PRKDC (0.53) CA12CA9GABRPGABRDGABRA1
SCHEMBL28386887 0.78 GABRP (0.51) CA12CA9GABRPGABRDGABRA1
SCHEMBL8115276 0.78 NOTUM (0.47) PTGS2MIFNOTUM
SCHEMBL6827354 0.78 CYP3A4 (0.60) MIFSLC9A1CYP1A1CYP1A2CYP1B1
SCHEMBL29369936 0.75 CYP3A4 (0.50) CA9GABRPGABRDGABRA1GABRB1
SCHEMBL30670392 0.75 CYP1A1 (0.50) MIFCYP1A1CYP1A2CYP1B1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6114546-A Aminomethylene derivatives and ultraviolet absorbent comprising thereof CHEMIPRO KASEI KAISHA, LIMITED (JP) 2000-09-05 US disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
CN-1236357-A Aminomethylene derivatives and ultraviolet absorber comprising the same CHEMIPRO KASEI KAISHA LTD (JP) 1999-11-24 CN disclosed
EP-0950655-A1 AMINOMETHYLENE DERIVATIVES AND ULTRAVIOLET ABSORBER COMPRISING THE SAME CHEMIPRO KASEI KAISHA, LIMITED (JP) 1999-10-20 EP disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed